Arlene N. Mahoney

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

University of Arizona(Current)

Arizona Science Center

Arizona Christian University

Harm Reduction Services

Indiana University Bloomington

Arlene N. Mahoney is an author at University of Arizona specializing in buprenorphine access policy, community-based treatment access, and pharmacy sale transactions.

ORCID

Publications per year

2022–2024

Publications

Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID

Beth E. Meyerson, Keith Gunnar Bentele, Danielle M. Russell et al. · PLoS ONE · 2022 · 28 citations · Full text

Law, Community Health, Health Services Research +14

Come back when you’re infected: pharmacy access to sterile syringes in an Arizona Secret Shopper Study, 2023

Danielle M. Russell, Beth E. Meyerson, Arlene N. Mahoney et al. · Harm Reduction Journal · 2024 · 14 citations · Full text

Pharmacy, Community Pharmacy, Pharmacy Practice +14

Insufficient Impact: Limited Implementation of Federal Regulatory Changes to Methadone and Buprenorphine Access in Arizona During COVID-19

Beth E. Meyerson, Keith Gunnar Bentele, Benjamin R. Brady et al. · AJPM Focus · 2023 · 13 citations · Full text

Pharmacy, Pharmacy Practice, Rural Health +14

<scp>SI‐CBPAR</scp>: Towards structural indicators of community‐based participatory action research

Beth E. Meyerson, Danielle M. Russell, Arlene N. Mahoney et al. · Drug and Alcohol Review · 2023 · 10 citations · Full text

Public Health, Community Health, Community Assessment +11

1–4 of 4